Vimarsana
Biggest News Aggregation in the World

Page 28 - Bd Becton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bd Becton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bd Becton Today - Breaking & Trending Today

BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System - Vimarsana News

BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System

Share this article Share this article FRANKLIN LAKES, N.J., May 25, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the availability of BD Surgiphor™ Sterile Wound Irrigation System, the first and only ready-to-use aqueous povidone-iodine (PVP-I) irrigation solution that mechanically loosens and removes wound debris. BD Surgiphor sterile wound irrigation system BD Surgiphor™ is a pre-mixed, pre-labeled, single patient surgical wound irrigation solution. BD Surgiphor™ uses PVP-I, a well-known antiseptic ag...

BD to Present at Upcoming Investor Health Care Conferences in May - Vimarsana News

BD to Present at Upcoming Investor Health Care Conferences in May

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the...

BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula - Vimarsana News

BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula

Share this article Share this article FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first patients have been treated in the post-market surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm, open-label study that will follow patients treated with the WavelinQ TM EndoAVF System for 24 months. WavelinQ EndoAVF System The study's dual primary effectiveness endpoints are the percentage of subjects dialyzing using successful 2-nee...

Elizabeth McCombs Appointed Chief Technology Officer at BD - Vimarsana News

Elizabeth McCombs Appointed Chief Technology Officer at BD

Elizabeth McCombs Appointed Chief Technology Officer at BD John DeFord to join newly formed external Scientific Advisory Board News provided by Share this article Share this article FRANKLIN LAKES, N.J., April 28, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Elizabeth McCombs as executive vice president and chief technology officer, effective April 26, 2021, succeeding John DeFord. McCombs, 45, will be responsible for continuing to drive the company's category innovation strategy and lead...

USATF Partners With BD To Provide Rapid COVID-19 Testing To Enhance Athlete Safety At Track & Field Events - Vimarsana News

USATF Partners With BD To Provide Rapid COVID-19 Testing To Enhance Athlete Safety At Track & Field Events

Share this article Share this article FRANKLIN LAKES, N.J., April 23, 2021 /PRNewswire/ -- USA Track & Field (USATF) and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide rapid COVID-19 testing for USATF athletes at Journey to Gold meets to help get USATF professional athletes back to competition safely through the use of the BD Veritor™ Plus system. USA Track & Field (USATF) and BD have partnered to provide rapid COVID-19 testing for USATF athletes at Journey to Gold meets to help get USATF professional athletes back to ...